SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-116440
Filing Date
2020-10-20
Accepted
2020-10-20 16:16:01
Documents
2
Period of Report
2020-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a20-33377_18k.htm 8-K 25625
2 EX-10.1 a20-33377_1ex10d1.htm EX-10.1 547819
  Complete submission text file 0001104659-20-116440.txt   574668
Mailing Address 5941 OPTICAL COURT SAN JOSE CA 95138
Business Address 5941 OPTICAL COURT SAN JOSE CA 95138 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 201248486
SIC: 2834 Pharmaceutical Preparations